BRIEF published on 10/14/2024 at 11:05, 1 month 7 days ago VAZIVA SA Organizes a Webinar for its 2024 Half-Year Results Shareholders Webinar VAZIVA Half-year Results France
BRIEF published on 10/08/2024 at 10:35, 1 month 13 days ago VAZIVA SA Organizes a Webinar for its Individual Shareholders Shareholders Webinar Strategy VAZIVA Half-year Results
BRIEF published on 10/01/2024 at 17:05, 1 month 19 days ago VAZIVA SA organizes a webinar for its individual shareholders Shareholders Webinar Development VAZIVA Half-yearly Results
BRIEF published on 09/25/2024 at 19:09, 1 month 25 days ago Vaziva SA: Half-Year Results 2024 Show Sharp Growth and Profitability Employee Benefits Profitability Growth VAZIVA Half-year Results
PRESS RELEASE published on 09/25/2024 at 19:04, 1 month 25 days ago VAZIVA SA: VAZIVA SA: HALF-YEAR RESULTS 2024 SHARP GROWTH AND PROFITABILITY FIGURES Vaziva SA reports significant growth in half-year results for 2024 with EBITDA (+130%), Operating Income (+133%), and Net Income (+122%). Company plans for international expansion 2024 International Expansion Growth VAZIVA SA Half-year Results
BRIEF published on 09/25/2024 at 18:10, 1 month 25 days ago VAZIVA SA: Half-Year Results 2024 - Growth and Profitability on the Rise Employee Benefits Profitability International Expansion Growth Half-year Results
BRIEF published on 07/26/2024 at 14:05, 3 months 25 days ago VAZIVA SA: Evolution of 155.3% in turnover in H1 2024 Growth VAZIVA Turnover CSE Spain
PRESS RELEASE published on 07/26/2024 at 14:00, 3 months 25 days ago VAZIVA SA: SALES UP 155.3% IN H1 2024 Vaziva SA reports a 155.3% increase in sales in H1 2024, strengthens sales teams for domestic expansion, and opens a subsidiary in Spain Employee Benefits Sales Increase VAZIVA SA Domestic Expansion Subisidiary In Spain
BRIEF published on 07/24/2024 at 17:50, 3 months 27 days ago VAZIVA SA: Change of 155.3% in turnover in H1 2024 International Expansion Turnover CSE Commercial Strategy Social Fintech
BRIEF published on 05/14/2024 at 16:20, 6 months 6 days ago VAZIVA SA Reports Significant Financial Growth and Strategic Investments in 2023 Market Expansion Financial Growth Strategic Investments Operational Profitability Key Account Sales
Published on 11/21/2024 at 13:30, 27 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 27 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 57 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 57 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 57 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 22 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 42 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
